HomeCompareLJUIF vs NNN

LJUIF vs NNN: Dividend Comparison 2026

LJUIF yields 4.97% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LJUIF wins by $76.9K in total portfolio value
10 years
LJUIF
LJUIF
● Live price
4.97%
Share price
$0.40
Annual div
$0.02
5Y div CAGR
31.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.4K
Annual income
$28,919.95
Full LJUIF calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — LJUIF vs NNN

📍 LJUIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLJUIFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LJUIF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LJUIF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LJUIF
Annual income on $10K today (after 15% tax)
$422.31/yr
After 10yr DRIP, annual income (after tax)
$24,581.96/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, LJUIF beats the other by $22,352.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LJUIF + NNN for your $10,000?

LJUIF: 50%NNN: 50%
100% NNN50/50100% LJUIF
Portfolio after 10yr
$64.0K
Annual income
$15,771.31/yr
Blended yield
24.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

LJUIF
No analyst data
Altman Z
2.6
Piotroski
4/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LJUIF buys
0
NNN buys
2
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$NNN▼ Sell$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$NNN▲ Buy$1,001 - $15,0002025-06-17
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002023-05-25
Ro Khanna🏢 House$NNN▼ Sell$1,001 - $15,0002022-01-20
Zoe Lofgren🏢 House$NNN▲ Buy$1,001 - $15,0002021-09-30
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002020-03-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLJUIFNNN
Forward yield4.97%5.66%
Annual dividend / share$0.02$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR31.6%8.6%
Portfolio after 10y$102.4K$25.5K
Annual income after 10y$28,919.95$2,622.67
Total dividends collected$73.4K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LJUIF vs NNN ($10,000, DRIP)

YearLJUIF PortfolioLJUIF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$11,354$653.83$10,735$614.96+$619.00LJUIF
2$13,062$913.02$11,572$708.43+$1.5KLJUIF
3$15,268$1,291.84$12,531$819.53+$2.7KLJUIF
4$18,194$1,857.20$13,633$952.29+$4.6KLJUIF
5$22,189$2,721.92$14,909$1,111.84+$7.3KLJUIF
6$27,825$4,082.89$16,392$1,304.77+$11.4KLJUIF
7$36,070$6,297.08$18,129$1,539.52+$17.9KLJUIF
8$48,635$10,039.66$20,173$1,827.08+$28.5KLJUIF
9$68,688$16,649.06$22,597$2,181.81+$46.1KLJUIF
10$102,416$28,919.95$25,491$2,622.67+$76.9KLJUIF

LJUIF vs NNN: Complete Analysis 2026

LJUIFStock

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.

Full LJUIF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this LJUIF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LJUIF vs SCHDLJUIF vs JEPILJUIF vs OLJUIF vs KOLJUIF vs MAINLJUIF vs ADCLJUIF vs EPRTLJUIF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.